NasdaqHealth CareBiological Products, (No Diagnostic Substances)PHOENIX, AZ

Creative Medical Technology Holdings, Inc. CELZ

Ask your AI

Estimated market cap $4.01M7.60M shares, shares as of Nov 6, 2026CIK 1187953

Insider trades, 12 mo

—

No open-market trades

Congress trades, 24 mo

—

No disclosed trades

13F holders, Q3 2026

62.4% of shares · 3 added

13F holders

…

Lobbying, 12 mo

—

No lobbying filings

Federal contracts, 12 mo

—

None matched

Ask your AI:

Latest 10-Q

Q3 2026

What changed in Creative Medical Technology Holdings, Inc.'s latest quarterly report, compared with the one before.

Filed Nov 6, 2026 · Quarter ended Sep 30, 2026

AI No AI summary for this 10-Q: management's discussion could not be compared, and the other sections did not change.

Compared with the 10-Q for the quarter ended Jun 30, 2026. Sections compared: legal proceedings.

Read the 10-Q on sec.gov ↗Filing index ↗

Latest 10-Q

What changed in Creative Medical Technology Holdings, Inc.'s latest quarterly report, compared with the one before.

Loading…

Insider trades

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

No open-market insider trades reported since Feb 19, 2025. Insiders have two business days to file.

Recent insider trades

Michael H. Finger Director	Feb 19, 2025 Form 4 ↗	Sale	−$4,313 750 sh @ $5.75	-114.5%
Michael H. Finger Director	Feb 18, 2025 Form 4 ↗	Sale	−$3,750 750 sh @ $5.00	-112.5%

All CELZ insider trades →Planned sales (Form 144): see notices

Insider trades

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

Loading…

13F holders

4.74M shares

13 funds report CELZ. Values checked against market prices.

Funds own 5.7% of shares (Q2 2026)

13 funds hold the stock.

Q3 2026: 62% · 5,560 of ~8,900 funds reported so far

Q2 20252.7%
Q3 20252.7%
Q4 20255.0%
Q1 20262.6%
Q2 20265.7%
Q3 2026 (so far)62%

Q3 2026. 5 new, 3 added to, 3 trimmed, 6 exited since Q2 2026.

Top 13F holders
#
1	MYDA Advisors LLC 13F ↗	4.50M	$4.2M	New
2	Acadian Asset Management LLC 13F ↗	81,293	$74.0K	New
3	Vanguard Fiduciary Trust Co 13F ↗	62,472	$58.4K	+1032.1%
4	Geode Capital Management, LLC 13F ↗	25,699	$24.0K	-0.4%
5	Vanguard Capital Management LLC 13F ↗	20,350	$19.0K	unchanged
6	HRT Financial LP 13F ↗	19,918	$18.0K	n/a
7	StoneX Group Inc. 13F ↗	15,266	$10.1K	New
8	Global Retirement Partners, LLC 13F ↗	8,618	$8,054	+109.3%
9	UBS Group AG 13F ↗	5,201	$4,863	+152.4%
10	Morgan Stanley 13F ↗	264	$247	-48.6%

2 of these funds report values in thousands of dollars; their figures are shown in dollars.

Download CSV Every fund that holds CELZ, not only these ten. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

13F holders

Funds that report this stock, checked against market prices.

Loading…

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

No recent congressional trades for this company.

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

Loading…

Lobbying

What Creative Medical Technology Holdings, Inc. and its lobbying firms report each quarter.

No recent lobbying filings for this company.

Lobbying

What Creative Medical Technology Holdings, Inc. and its lobbying firms report each quarter.

Loading…

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Funds holding the stock

Shares they report

Funds holding the stock by quarter

Q2 2023	9	—	20,745	$96.2K
Q3 2023	8	-1	21,203	$104.3K
Q4 2023	8	0	19,632	$90.5K
Q1 2024	13	+5	106,170	$552.1K
Q2 2024	9	-4	69,358	$267.0K
Q3 2024	10	+1	69,186	$213.8K
Q4 2024	8	-2	29,860	$71.2K
Q1 2025	11	+3	201,588	$437.1K
Q2 2025	12	+1	69,948	$185.4K
Q3 2025	12	0	70,724	$233.4K
Q4 2025	14	+2	128,862	$252.6K
Q1 2026	11	-3	96,765	$199.3K
Q2 2026	13	+2	372,588	$540.3K
Q3 2026	13	0	4.74M	$4.4M

Each point is a quarter-end, from Q2 2023 to Q3 2026. A fund's 13F lists its long positions in US-listed securities as of the last day of the quarter and arrives up to 45 days later, so each point shows holdings at quarter-end, not on the day they were reported.

Common shares only; options and bonds are left out. When a fund amends a report, the amended version is the one counted.

The history follows the company's current CUSIP number (22529Y408). If the company's shares were ever re-issued under a different CUSIP, the quarters before the change are not part of this series, so the first point (Q2 2023) can be later than the stock's first appearance in 13F reports.

Share counts are adjusted for stock splits; none took place between these quarters. Values are in dollars as reported at the time and are not adjusted.

A quarter appears once our daily update has built its summary. If a summary cannot be built, older reports are kept and the chart shows the quarters it has until the next update repairs it.

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Loading…

More filings and data

Each opens the table.

Ownership stakes1 in 12 mo 8-K events3 in 90 days Patents4 patents granted Short interestFINRA · updated Oct 15 Planned insider salesNone in 12 mo Executive payNone on record Wikipedia attentionNone on record SEC enforcementNone on record Clinical trials3 active IPO history5 registrations Ownership stakes…8-K events…Patents…Short interest…Planned insider sales…Executive pay…Wikipedia attention…SEC enforcement…

About the company

The basics from the company’s SEC registration.

Legal name: CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
Address: 211 E. OSBORN RD., PHOENIX, AZ 85012
Phone: 480-399-2822
Fiscal year ends: Dec 31
Filer category: Non-accelerated filer, smaller reporting company
Incorporated in: NV
Listed as: CELZ (Nasdaq)
Former names: JOLLEY MARKETING INC (until 2016)
SEC filings: All filings on SEC EDGAR ↗

About the company

The basics from the company’s SEC registration.

Loading…

$0.5281−$0.09 (−14.35%) Nov 13 close

1M3M1Y

Oct 13, 2026Low $0.5281 · High $0.8199Nov 13, 2026

Aug 13, 2026Low $0.5281 · High $1.31Nov 13, 2026

Nov 13, 2025Low $0.5281 · High $3.15Nov 13, 2026

Congress purchase Congress sale Insider sale over $1M

Adjusted for stock splits; not for dividends. Where prices come from.

Live chart

Intraday and historical prices from TradingView. Quotes may be delayed.

Loading chart…

Information, not investment advice. Company matching is automatic; check the source before relying on one row.